Vitex (Chaste Tree Berry).

Vitex acts partly through dopamine D2 receptor agonism at the pituitary, and B6 is the cofactor for the decarboxylase that makes dopamine itself. Cycle formulas pair them because both feed the same dopaminergic control of prolactin.

Magnesium is a cofactor in the enzymes that make and clear steroid hormones and in the NMDA and GABA balance that shapes premenstrual comfort. It sits alongside vitex in cycle-support blends without acting on the same receptor.

Evening primrose supplies gamma-linolenic acid, which feeds the series-1 prostaglandin route involved in normal breast and cycle comfort. That is a lipid pathway separate from vitex's action at the pituitary.

Black cohosh triterpene glycosides act on serotonergic and central thermoregulatory signalling while vitex acts on pituitary dopamine and prolactin. Midlife hormonal formulas carry both because they cover different levers.

Velvet bean supplies levodopa that becomes dopamine, and vitex diterpenes act directly at the D2 receptor that dopamine binds. The dopaminergic signal is additive, so the two should be counted as one load rather than two.

St John's wort induces CYP3A4 and P-glycoprotein, which changes the clearance of many co-ingredients sharing a product with it. Its own action is on monoamine reuptake, a route separate from vitex at the pituitary D2 receptor.

Chamomile is a long-standing companion to chaste tree in European herbal formulations aimed at cyclical comfort. Its apigenin binds at benzodiazepine sites in receptor assays, which is a laboratory finding rather than a clinical demonstration. The pairing is conventional rather than tested as a combination. Anyone already using a sedating product should account for the additive direction.

Lemon balm appears alongside chaste tree in classic European formulations for cyclical tension. Its rosmarinic acid inhibits GABA transaminase in enzyme assays, a mechanism described in vitro and not confirmed as the clinical route. The two are usually combined for complementary rather than overlapping reasons. The additive direction on calm is the thing to note.

Chaste tree diterpenes bind dopamine D2 receptors on pituitary lactotrophs and lower prolactin secretion. Ashwagandha withanolides have been studied for effects on cortisol measures, a different arm of the same hypothalamic-pituitary system. The two touch neighbouring endocrine controls rather than the same one. No trial of the combination is cited here, so this stays a mechanistic pairing.

Chaste tree acts through dopaminergic modulation at the pituitary, and rhodiola constituents have been described as altering monoamine turnover including dopamine. Where two products both touch dopaminergic tone, the combined effect is not simply additive and depends on site. The pairing is common in fatigue and cycle-support formulations. Read it as mechanistic overlap worth flagging rather than a demonstrated benefit.

Dang gui occupies a similar place in Chinese herbal practice to the one chaste tree occupies in European practice. Modern combination products frequently carry both. The grounding here is the tradition and the formulation convention, not a trial. Dang gui also has coumarin constituents, so anyone on blood-thinning medication should raise it with a clinician.

Licorice is a frequent companion to chaste tree in cycle formulations, but its glycyrrhizin blocks the enzyme that inactivates cortisol at the mineralocorticoid receptor. That raises sodium retention and lowers potassium in a dose and duration dependent way. Deglycyrrhizinated licorice does not carry that effect. The pairing is worth naming for the licorice pharmacology, which is settled, rather than for a combined benefit.

Red clover supplies genistein, daidzein, biochanin A and formononetin, which occupy oestrogen receptors with a preference for the beta subtype. Chaste tree by contrast acts upstream at the pituitary through dopamine receptors and is not itself an oestrogen receptor ligand at usual intakes. Combining them means acting at two different points of the same axis. Anyone with a hormone-sensitive history should raise the combination with a clinician.

Calcium has been studied for cyclical symptom scores in randomised work, and the route proposed is mineral status rather than pituitary signalling. Chaste tree acts on prolactin release. Two independent routes are the reason the pairing appears in formulations. No combination trial is cited here, so the pairing is additive by construction rather than by measurement.

Zinc sits in delta-6 desaturase, which converts linoleic acid toward the prostaglandin precursors, and in numerous hormone receptor zinc fingers. Evening primrose oil, already a stored partner here, supplies that same fatty acid pathway. Zinc status therefore sits between the oil and its downstream mediators. The relationship is cofactor chemistry.

Theanine is the amino acid of tea leaf and produces measurable shifts in alpha-band EEG activity within an hour of intake. It is combined with cycle-support botanicals for calm without sedation. Chaste tree does not act by that route, so the pairing is complementary. The additive direction on calm is what to keep in view.

Passionflower is a conventional companion in cyclical-comfort blends and its flavonoid fraction interacts with GABA-A receptors in binding studies. That is receptor-level evidence, not a clinical outcome for the pair. Sedation is additive when combined with other calming botanicals or with medication acting the same way. Timing to evening is the usual formulation answer.

Silymarin has been shown in vitro to inhibit CYP2C9, CYP3A4 and glucuronidation, though the clinical significance at ordinary intakes is modest and inconsistent across human studies. Chaste tree constituents undergo phase two conjugation, so a shared conjugation route is plausible. The two appear together in liver-and-hormone formulations. Flag it as a metabolic interaction to watch rather than a benefit.

Ginger constituents reduce prostaglandin and leukotriene formation in laboratory systems, and prostaglandins drive uterine smooth muscle contraction. Chaste tree acts higher up, on prolactin release from the pituitary. Combining them covers two levels of the same picture. Ginger also has a mild antiplatelet direction worth noting alongside blood-thinning medication.

Vitamin B6 is already a stored partner here for its role in amine metabolism, and riboflavin sits alongside it as the flavin cofactor of the same one-carbon cycle. Riboflavin is also required for the reductive steps that recycle catechol intermediates of steroid hormone metabolism. Where B6 is being supplied for cyclical support, riboflavin covers the adjacent cofactor. The link is settled biochemistry.

Steroid hormones and many botanical constituents are conjugated to glucuronides for excretion, and bacterial beta-glucuronidase can cleave them back for reabsorption. Glucaro-1,4-lactone inhibits that enzyme, which shifts the balance toward excretion. That is enzyme chemistry with a clear direction, not a demonstrated clinical effect. It also means it could alter the exposure of anything else cleared by glucuronidation.

DIM arises from indole-3-carbinol in the stomach and induces CYP1A1, changing the ratio of 2-hydroxy to 16-alpha-hydroxy oestrogen metabolites. Chaste tree acts on prolactin release rather than on oestrogen metabolism, so the two touch different steps of the same axis. That is why both appear in the same product category. Enzyme induction also means DIM can change how other compounds are cleared.

Ginkgo appears in some cyclical-comfort formulations alongside chaste tree. Ginkgolide B antagonises platelet-activating factor, an established pharmacological property, which makes the additive direction on bleeding time the point worth stating. That direction matters more here than any combined benefit. Anyone on antiplatelet or anticoagulant medication should discuss it with a clinician.

Chaste tree acts through dopamine receptors, and dopaminergic tone is one input to the circuits that time melatonin release. Melatonin in turn feeds back onto hypothalamic reproductive signalling. The two therefore touch overlapping control loops. This is neuroendocrine mechanism, described in laboratory and animal work rather than shown in a combination trial.